£107.67

Springer Evolution-adjusted Tumor Pathophysiology:: The Novel Language of Tumor Biology

Price data last checked 69 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£108 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 22 days • 22 data points (No recent data available)

Historical
Generating forecast...
£112.59 £107.18 £108.36 £109.54 £110.72 £111.90 £113.08 11 March 2026 16 March 2026 21 March 2026 26 March 2026 01 April 2026

Price Distribution

Price distribution over 22 days • 2 price levels

Days at Price
Current Price
8 days · current 14 days 0 4 7 11 14 £108 £113 Days at Price

Price Analysis

Most common price: £113 (14 days, 63.6%)

Price range: £108 - £113

Price levels: 2 different prices over 22 days

Description

Combined modularized therapies for metastatic cancer are pointing to central problems of communication among ‘systems participators’. A communication theory explains 'social engineering', endogenously induced or by implementing non-normative boundary conditions. Evolution-adjusted tumor pathophysiology is borne by an evolution theory, which contrasts narrative evolution histories. The tool of rationalizations constituting the tumor's normativity (inflammation, immune response etc.) represents the non-genomic counterpart of the tumor genome and should be additionally assessed during tumor staging. Evolution-adjusted tumor pathophysiology allows implementing applied systems biology, a novel clinical and pharmaceutical technology for bioengineering tumor response and personalizing tumor therapy. Combined modularized therapy, evolution-adjusted tumor pathophysiology, and ‘universal’ biomarkers concertedly address genetically based tumor heterogeneity. From the Back Cover Combined modularized therapies for metastatic cancer are pointing to central problems of communication among ‘systems participators’. A communication theory explains 'social engineering', endogenously induced or by implementing non-normative boundary conditions. Evolution-adjusted tumor pathophysiology is borne by an evolution theory, which contrasts narrative evolution histories. The tool of rationalizations constituting the tumor's normativity (inflammation, immune response etc.) represents the non-genomic counterpart of the tumor genome and should be additionally assessed during tumor staging. Evolution-adjusted tumor pathophysiology allows implementing applied systems biology, a novel clinical and pharmaceutical technology for bioengineering tumor response and personalizing tumor therapy. Combined modularized therapy, evolution-adjusted tumor pathophysiology, and ‘universal’ biomarkers concertedly address genetically based tumor heterogeneity.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Springer - Signaling Pathways and Molecular Mediators in Metastasis
98% match

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Springer

£114.94 20 Apr 2026
Evolution-adjusted Tumor Pathophysiology:: The Novel Language of Tumor Biology
98% match

Evolution-adjusted Tumor Pathophysiology:: The Novel Language of Tumor Biology

Springer

£108.75 12 Jan 2026
Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)
98% match

Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)

Springer

£114.20 13 Apr 2026
Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)
98% match

Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)

Springer

£114.20 30 Mar 2026
Molecular Biology of Human Cancers
98% match

Molecular Biology of Human Cancers

£76.67 12 Jan 2026
Molecular Biology of Human Cancers
98% match

Molecular Biology of Human Cancers

£96.11 13 Jan 2026
Oxford Textbook of Cancer Biology (Oxford Textbooks in Oncology)
97% match

Oxford Textbook of Cancer Biology (Oxford Textbooks in Oncology)

Oxford University Press

£135.90 18 Mar 2026
Abeloff's Clinical Oncology
97% match

Abeloff's Clinical Oncology

Elsevier

£200.00 22 Jan 2026
Advances in Cancer Research: 77: Volume 77
97% match

Advances in Cancer Research: 77: Volume 77

Academic Press

£90.19 08 Mar 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)
97% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)

Springer

£175.38 08 Apr 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)
97% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)

Springer

£174.97 28 Mar 2026
Holland-Frei Cancer Medicine - Volume 1 and 2
97% match

Holland-Frei Cancer Medicine - Volume 1 and 2

Wiley-Blackwell

£137.02 09 Dec 2025
Evidence–Based Oncology (Evidence–Based Medicine)
97% match

Evidence–Based Oncology (Evidence–Based Medicine)

Wiley-Blackwell

£175.00 23 Jan 2026
Cancer Biology
97% match

Cancer Biology

Oxford University Press

£69.50 27 Feb 2026
Oncogenes: 47 (Cancer Treatment and Research, 47)
97% match

Oncogenes: 47 (Cancer Treatment and Research, 47)

Springer

£148.77 25 Jan 2026
Manual of Clinical Oncology, Fourth Edition Fully Revised (UICC International Union Against Cancer)
97% match

Manual of Clinical Oncology, Fourth Edition Fully Revised (UICC International Union Against Cancer)

Springer

£89.99 01 Mar 2026
Introduction to Mathematical Oncology (Chapman & Hall/CRC Mathematical Biology Series)
97% match

Introduction to Mathematical Oncology (Chapman & Hall/CRC Mathematical Biology Series)

CRC Press

£49.39 26 Feb 2026
UICC Manual of Clinical Oncology
97% match

UICC Manual of Clinical Oncology

Wiley

£119.69 06 Feb 2026
Cancer Microenvironment and Therapeutic Implications: Tumor Pathophysiology Mechanisms and Therapeutic Strategies
97% match

Cancer Microenvironment and Therapeutic Implications: Tumor Pathophysiology Mechanisms and Therapeutic Strategies

Springer

£109.08 13 Mar 2026
Cancer Microenvironment and Therapeutic Implications: Tumor Pathophysiology Mechanisms and Therapeutic Strategies
97% match

Cancer Microenvironment and Therapeutic Implications: Tumor Pathophysiology Mechanisms and Therapeutic Strategies

Springer

£106.25 04 Apr 2026
Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)
97% match

Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)

Humana

£141.36 10 Mar 2026
Mathematical Oncology 2013 (Modeling and Simulation in Science, Engineering and Technology)
97% match

Mathematical Oncology 2013 (Modeling and Simulation in Science, Engineering and Technology)

Birkhauser

£73.85 03 Apr 2026
Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy: 1036 (Advances in Experimental Medicine and Biology, 1036)
97% match

Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy: 1036 (Advances in Experimental Medicine and Biology, 1036)

Springer

£125.98 11 Jan 2026
Selected Topics in Clinical Oncology: An in-depth Study of 18 Cancers Usually Neglected in Classical Textbooks
97% match

Selected Topics in Clinical Oncology: An in-depth Study of 18 Cancers Usually Neglected in Classical Textbooks

Springer

£120.89 28 Jan 2026